RPL39L
Ribosomal protein eL39-like 2
Also known as: RL39L_HUMAN, RPL39L1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96EH5
- Gene
- RPL39L
- Ensembl
- ENSG00000163923
- Chromosome
- 3
- Canonical length
- 51 aa
- Protein class
- Predicted intracellular proteins, Ribosomal proteins
OverviewNCBI Gene
This gene encodes a protein sharing high sequence similarity with ribosomal protein L39. Although the name of this gene has been referred to as 'ribosomal protein L39' in the public databases, its official name is 'ribosomal protein L39-like'. It is not currently known whether the encoded protein is a functional ribosomal protein or whether it has evolved a function that is independent of the ribosome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
51 residues, UniProt reviewed canonical sequence.
>Q96EH5|RPL39L
1 MSSHKTFTIK RFLAKKQKQN RPIPQWIQMK PGSKIRYNSK RRHWRRTKLG LLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL39L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 210 nTPM
Expression across tissuesHPA
Tissue
- testis: 210 nTPM
- blood vessel: 24 nTPM
- pancreas: 19 nTPM
- bone marrow: 18 nTPM
- thymus: 15 nTPM
- tonsil: 13 nTPM
Single-cell type
- late primary spermatocytes: 1,482 nCPM
- early spermatids: 414 nCPM
- early primary spermatocytes: 412 nCPM
- oocytes: 355 nCPM
- late spermatids: 269 nCPM
- differentiating spermatogonia: 134 nCPM
Immune cell
- T-reg: 48 nTPM
- memory B-cell: 33 nTPM
- total PBMC: 31 nTPM
- naive CD8 T-cell: 26 nTPM
- memory CD4 T-cell: 25 nTPM
- gdT-cell: 25 nTPM
Brain region
- cerebellum: 34 nTPM
- hypothalamus: 34 nTPM
- white matter: 33 nTPM
- cerebral cortex: 29 nTPM
- thalamus: 29 nTPM
- choroid plexus: 28 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL39L as an antibody target. Whether an autoantibody or antibody against RPL39L could matter depends on whether native RPL39L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL39L is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL39L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...